Kansai Nerolac Paints Limited Announces 106th AGM and FY 2025-26 Annual Report

Kansai Nerolac Paints Limited announced its 106th Annual General Meeting (AGM) scheduled for Thursday, 9th July 2026, at 11 a.m. IST, to be conducted via Video Conferencing. The company also informed that the Annual Report for the financial year 2025-26, along with the AGM notice, is now available on its website and the stock exchanges. Shareholders are encouraged to update their KYC details to ensure smooth dividend remittance and for seamless participation.

106th Annual General Meeting Scheduled

Kansai Nerolac Paints Limited has announced that its 106th Annual General Meeting (AGM) will be held on Thursday, July 9, 2026, at 11:00 AM IST. The meeting will be conducted virtually through Video Conferencing and Other Audio Visual Means (VC/OAVM), ensuring no physical presence of shareholders is required.

Annual Report 2025-26 Available

The Annual Report for the financial year 2025-26, including the Notice of the AGM, is now accessible on the company’s website (www.nerolac.com) and the websites of the Stock Exchanges (BSE and NSE), as well as NSDL for e-voting. Shareholders can also obtain a physical copy upon request.

Key AGM Details and Dividend Information

The record date for dividend determination is set as Monday, June 29, 2026. E-voting will commence on Monday, July 6, 2026, at 9 a.m. IST, and conclude on Wednesday, July 8, 2026, at 5 p.m. IST. Dividend payments, if declared, will be processed on or after Tuesday, July 14, 2026.

Shareholder Support and KYC Update

Shareholders are encouraged to update their KYC details, including email IDs, by contacting their Depository Participant for demat holdings or the Registrar and Transfer Agents for physical holdings. This will facilitate seamless communication and prevent the transfer of unclaimed dividends to the IEPF authority.

Source: BSE

Previous Article

Anupam Rasayan India Ltd. Becomes World's First to Commercialize ETFA Using Flow Chemistry

Next Article

Dabur India Ltd. US FDA Issues Import Alert for Silvassa Plant